Micro- organisms |
Patients Groups |
Overall | Initial PPD > 4 mm | ||||
---|---|---|---|---|---|---|---|
Baseline | 3 months | 6 months | Baseline | 3 months | 6 months | ||
Pg | Control | 7.36 ± 2.29 | 2.63 ± 0.72a | 1.39 ± 0.44a | 7.97 ± 0.24 | 3.04 ± 0.98a | 1.68 ± 0.57 |
Experimental | 5.44 ± 1.37 | 3.28 ± 0.82a | 2.49 ± 0.65a | 5.97 ± 1.27 | 2.98 ± 0.81a | 3.22 ± 0.89a | |
Tf | Control | 4.20 ± 1.57 | 0.75 ± 0.28 | 0.83 ± 0.24 | 4.39 ± 1.64 | 0.95 ± 0.42 | 1.01 ± 0.27 |
Experimental | 4.26 ± 0.83 | 1.77 ± 0.49 | 1.22 ± 0.50 | 4.78 ± 0.96 | 1.53 ± 0.52 | 1.81 ± 0.63 | |
Td | Control | 3.03 ± 1.54 | 0.88 ± 0.23 | 0.74 ± 0.38 | 2.86 ± 1.48 | 0.99 ± 0.34 | 1.01 ± 0.56 |
Experimental | 4.15 ± 0.79 | 1.75 ± 0.59 | 1.54 ± 0.43a | 4.12 ± 0.82 | 2.17 ± 0.75 | 2.27 ± 0.61 |
aStatistically significant difference from baseline (Wilcoxon Signed Ranks test, P < 0.05).
|